Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Assets Average (2021 - 2025)

Historic Assets Average for InMed Pharmaceuticals (INM) over the last 5 years, with Q4 2025 value amounting to $12.3 million.

  • InMed Pharmaceuticals' Assets Average rose 2944.62% to $12.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $12.3 million, marking a year-over-year increase of 2944.62%. This contributed to the annual value of $13.7 million for FY2025, which is 568.36% up from last year.
  • InMed Pharmaceuticals' Assets Average amounted to $12.3 million in Q4 2025, which was up 2944.62% from $14.5 million recorded in Q3 2025.
  • In the past 5 years, InMed Pharmaceuticals' Assets Average registered a high of $18.4 million during Q4 2021, and its lowest value of $8.9 million during Q1 2025.
  • Over the past 5 years, InMed Pharmaceuticals' median Assets Average value was $13.7 million (recorded in 2022), while the average stood at $13.6 million.
  • The largest annual percentage gain for InMed Pharmaceuticals' Assets Average in the last 5 years was 2985.14% (2025), contrasted with its biggest fall of 3785.55% (2025).
  • InMed Pharmaceuticals' Assets Average (Quarter) stood at $18.4 million in 2021, then decreased by 14.18% to $15.8 million in 2022, then fell by 16.92% to $13.1 million in 2023, then decreased by 27.53% to $9.5 million in 2024, then rose by 29.45% to $12.3 million in 2025.
  • Its Assets Average was $12.3 million in Q4 2025, compared to $14.5 million in Q3 2025 and $12.4 million in Q2 2025.